HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V M Kosma Selected Research

Transcription Factor AP-2

7/2001Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
6/2000Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.
6/2000Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V M Kosma Research Topics

Disease

17Neoplasms (Cancer)
03/2007 - 01/2000
9Carcinoma (Carcinomatosis)
11/2007 - 01/2000
5Prostatic Neoplasms (Prostate Cancer)
07/2001 - 08/2000
5Breast Neoplasms (Breast Cancer)
06/2001 - 02/2000
4Neoplasm Metastasis (Metastasis)
07/2001 - 12/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2002 - 01/2001
3Adenocarcinoma
07/2001 - 01/2001
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2001 - 09/2000
2Carcinogenesis
11/2007 - 12/2000
2Colorectal Neoplasms (Colorectal Cancer)
07/2001 - 11/2000
2Aneuploidy (Aneuploid)
07/2001 - 02/2001
2Thyroid Neoplasms (Thyroid Cancer)
12/2000 - 11/2000
2Margins of Excision
11/2000 - 08/2000
2Urinary Bladder Neoplasms (Bladder Cancer)
10/2000 - 07/2000
2Melanoma (Melanoma, Malignant)
09/2000 - 06/2000
2Ovarian Epithelial Carcinoma
06/2000 - 01/2000
1Inflammation (Inflammations)
03/2007
1Necrosis
03/2007
1Squamous Cell Neoplasms (Squamous Cell Cancer)
11/2001
1Adenoma (Adenomas)
07/2001
1Large Cell Carcinoma
05/2001
1Squamous Cell Carcinoma of Head and Neck
01/2001
1Stomach Neoplasms (Stomach Cancer)
01/2001
1Synovitis
01/2001
1Fistula
01/2001
1Papillary Carcinoma
12/2000
1Wounds and Injuries (Trauma)
07/2000
1Ovarian Neoplasms (Ovarian Cancer)
06/2000
1Monosomy
06/2000
1Colonic Neoplasms (Colon Cancer)
02/2000
1Rectal Neoplasms (Rectal Cancer)
02/2000
1Aspartylglucosaminuria
02/2000
1Residual Neoplasm
01/2000
1Cholangiocarcinoma
01/2000
1Liver Cell Adenoma (Hepatocellular Adenoma)
01/2000
1Bile Duct Adenoma
01/2000

Drug/Important Bio-Agent (IBA)

7Hyaluronic Acid (Hyaluronan)IBA
09/2002 - 01/2000
6Proteins (Proteins, Gene)FDA Link
03/2007 - 01/2000
6Protein Isoforms (Isoforms)IBA
07/2001 - 09/2000
4alpha Catenin (alpha E-Catenin)IBA
09/2002 - 11/2000
4Messenger RNA (mRNA)IBA
07/2001 - 06/2000
4CateninsIBA
05/2001 - 11/2000
3DNA (Deoxyribonucleic Acid)IBA
07/2001 - 10/2000
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2001 - 08/2000
3Transcription Factor AP-2IBA
07/2001 - 06/2000
3gamma Catenin (Plakoglobin)IBA
05/2001 - 12/2000
3ParaffinIBA
10/2000 - 02/2000
2RacivirIBA
11/2007 - 09/2007
2ORALIT (ORS)IBA
06/2001 - 03/2001
2beta CateninIBA
05/2001 - 01/2001
2Glycoproteins (Glycoprotein)IBA
01/2001 - 02/2000
2Prostate-Specific Antigen (Semenogelase)IBA
11/2000 - 08/2000
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2000 - 06/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2007
1CytokinesIBA
03/2007
1Interleukin-6 (Interleukin 6)IBA
03/2007
1ChemokinesIBA
03/2007
1Biological ProductsIBA
09/2002
1N 30IBA
07/2001
1Hormones (Hormone)IBA
06/2001
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
06/2001
1Superoxide DismutaseIBA
05/2001
1glutathione S-transferase M1IBA
03/2001
1Glutathione Transferase (Glutathione S-Transferase)IBA
03/2001
1Alcian BlueIBA
01/2001
1ChondroitinIBA
01/2001
1Tissue Inhibitor of MetalloproteinasesIBA
01/2001
1Matrix Metalloproteinase 3 (Stromelysin 1)IBA
01/2001
1Phospholipases (Phospholipase)IBA
01/2001
1Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2001
1Polychlorinated Dibenzodioxins (TCDD)IBA
12/2000
1DioxinsIBA
12/2000
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2000
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
12/2000
1SteroidsIBA
12/2000
1Capsules (Microcapsules)IBA
11/2000
1Cyclin D1IBA
10/2000
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
09/2000
1LigandsIBA
09/2000
11-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2000
1A-Form DNA (A-DNA)IBA
06/2000
1Transcription Factors (Transcription Factor)IBA
06/2000
1Codon (Codons)IBA
02/2000
1Aspartylglucosylaminase (Aspartylglucosaminidase)IBA
02/2000
13- chloro- 4- (dichloromethyl)- 5- hydroxy- 2(5H)- furanone (mutagen X)IBA
01/2000
1MutagensIBA
01/2000
1ChlorineIBA
01/2000
1beta-Galactosidase (Lactaid)IBA
01/2000

Therapy/Procedure

4Therapeutics
07/2000 - 01/2000
2Prostatectomy (Retropubic Prostatectomy)
11/2000 - 08/2000
1Ligation
09/2007
1Radiotherapy
11/2001
1Length of Stay
01/2001
1Laryngectomy
01/2001
1Pharyngectomy
01/2001
1Neck Dissection (Radical Neck Dissection)
01/2001
1Photochemotherapy (Photodynamic Therapy)
07/2000
1Enzyme Therapy
02/2000
1Enzyme Replacement Therapy
02/2000